
Regeneron reports COVID-19 antibody cocktail reduced infection risk by 82% for 8 months — so far
Fox News
Biotech giant Regeneron has claimed that its antibody cocktail reduces the risk of COVID-19 infection by nearly 82% for eight months.
"During the 8-month assessment period, there were 0 hospitalizations for COVID-19 in the REGEN-COV group and 6 in the placebo group," Regeneron said in a press release. "The fully human antibodies in REGEN-COV were developed to provide long-lasting protective effects without any artificial mutations or sequences."
No deaths occurred either.
More Related News

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












